GUANZE MEDICAL (02427) announced its interim results, reporting a loss attributable to shareholders of 38.804 million yuan, a year-on-year change from profit to loss.

date
22:39 31/08/2026
avatar
GMT Eight
GUANZE MEDICAL (02427) announced its performance for the six months ending June 30, 2026, during which the group achieved revenue of RMB 28.432 million, a decrease of 10.75% year-on-year; the loss attributable to equity holders of the company amounted to RMB 38.804 million, a shift from profit to loss compared to the same period last year; basic loss per share was RMB 0.041.
GUANZE MEDICAL (02427) announced its performance for the six months ending June 30, 2026, during which the group achieved revenue of 28.432 million RMB, a year-on-year decrease of 10.75%; the loss attributable to shareholders amounted to 38.804 million RMB, turning from profit to loss compared to the previous year; the basic loss per share was 0.041 RMB. The decrease in total revenue during the period was mainly due to a reduction in sales of medical imaging software.